Stock ScreenerStock IdeasHigh Risk, High Reward
High Risk, High Reward Stocks
Speculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!

Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
Ticker
Company
Zen Rating
Growth
Market Cap
Revenue
EBITDA
Earnings
EPS
Rev. Y/Y
Rev. 5Y
Earn. Y/Y
Earn. 5Y
Earnings Date
VNRX
VOLITIONRX LTD
$3.55M$2.46M-$23.33M-$26.10M-$3.8286.32%111.55%N/AN/A2026-11-12
NRSN
NEUROSENSE THERAPEUTICS LTD
$10.34M$0.00-$11.11M-$11.13M-$8.80N/AN/AN/AN/A
XAIR
BEYOND AIR INC
$2.96M$7.69M-$25.39M-$33.49M-$64.0060.75%64.20%N/AN/A2026-11-09
LGVN
LONGEVERON INC
$7.94M$1.19M-$22.46M-$23.47M-$9.90-42.74%-21.21%N/AN/A2026-11-03
VVOS
VIVOS THERAPEUTICS INC
$3.28M$20.90M-$23.67M-$25.46M-$1.9045.21%7.52%N/AN/A
CNTX
CONTEXT THERAPEUTICS INC
$33.81M$0.00-$45.81M-$45.96M-$0.48N/AN/AN/AN/A2026-11-04
DVLT
DATAVAULT AI INC
$142.46M$46.86M-$156.73M-$173.47M-$0.01955.84%60.65%N/AN/A
GOVX
GEOVAX LABS INC
$2.63M$0.00-$20.37M-$20.43M-$9.59N/A-100.00%N/AN/A2026-11-12
ITRG
INTEGRA RESOURCES CORP
$564.30M$258.35M$56.96M$10.68M$0.0474.04%N/A-66.67%N/A2026-11-11
IVVD
INVIVYD INC
$222.54M$58.37M-$105.32M-$107.33M-$0.3326.30%N/AN/AN/A2026-11-05
EVTL
VERTICAL AEROSPACE LTD
$87.60M$0.00$11.11M$878.54k-$0.09N/A-100.00%N/AN/A2026-11-03
TENX
TENAX THERAPEUTICS INC
$71.11M$0.00-$64.86M-$64.86M-$1.48N/AN/AN/AN/A2026-11-11
GUTS
FRACTYL HEALTH INC
$95.51M$0.00-$102.85M-$105.65M-$0.88-100.00%N/AN/AN/A2026-11-11
ELTX
ELICIO THERAPEUTICS INC
$49.67M$0.00-$35.12M-$37.84M-$2.17N/A-100.00%N/AN/A2026-11-12
ACTU
ACTUATE THERAPEUTICS INC
$23.56M$0.00-$20.43M-$20.45M-$0.87N/AN/AN/AN/A2026-11-12
KSCP
KNIGHTSCOPE INC
$26.92M$20.71M-$41.75M-$45.00M-$3.4388.02%42.90%N/AN/A2026-11-11
ANVS
ANNOVIS BIO INC
$48.57M$0.00-$49.52M-$49.52M-$1.79N/AN/AN/AN/A2026-11-11
NRXP
NRX PHARMACEUTICALS INC
$143.74M$3.39M-$21.86M-$23.48M-$0.55N/AN/AN/AN/A
VERU
VERU INC
$41.09M$0.00-$13.50M-$13.61M-$0.58N/A-100.00%N/AN/A
CRVO
CERVOMED INC
$36.74M$331.30k-$30.35M-$30.35M-$3.22-95.74%N/AN/AN/A2026-11-06
NMRA
NEUMORA THERAPEUTICS INC
$137.16M$0.00-$205.98M-$212.75M-$1.23N/AN/AN/AN/A2026-11-05
GRI
GRI BIO INC
$4.22M$0.00-$9.66M-$9.66M-$15.12N/A-100.00%N/AN/A
BEAT
HEARTBEAM INC
$22.71M$0.00-$20.19M-$20.30M-$0.51N/AN/AN/AN/A2026-11-12
ATOS
ATOSSA THERAPEUTICS INC
$22.15M$0.00-$37.69M-$37.71M-$4.45N/AN/AN/AN/A2026-11-11
HUMA
HUMACYTE INC
$162.79M$2.12M-$79.19M-$96.74M-$0.51159.29%2.41%N/AN/A2026-11-11
OCGN
OCUGEN INC
$359.46M$4.58M-$70.35M-$81.81M-$0.26-3.66%N/AN/AN/A2026-11-04
RANI
RANI THERAPEUTICS HOLDINGS INC
$120.16M$4.88M-$26.34M-$30.14M-$0.15306.42%9.95%N/AN/A2026-11-05
OTLK
OUTLOOK THERAPEUTICS INC
$158.97M-$1.16M-$62.31M-$61.12M-$0.77N/AN/AN/AN/A
INTZ
INTRUSION INC
$14.95M$5.79M-$9.27M-$11.07M-$0.55-15.23%-3.68%N/AN/A2026-11-10
LESL
LESLIE's INC
$3.89M$1.18B-$163.72M-$250.49M-$27.02-5.68%-2.18%N/AN/A
CMPX
COMPASS THERAPEUTICS INC
$342.17M$0.00-$71.96M-$73.45M-$0.39N/AN/AN/AN/A2026-11-04
TARA
PROTARA THERAPEUTICS INC
$209.79M$0.00-$69.67M-$70.02M-$1.36N/AN/AN/AN/A2026-11-09
SION
SIONNA THERAPEUTICS INC
$269.47M$0.00-$94.77M-$97.38M-$2.17N/AN/AN/AN/A2026-11-04
OSTX
OS THERAPIES INC
$81.64M$0.00-$38.79M-$39.37M-$1.09N/AN/AN/AN/A
RNTX
REIN THERAPEUTICS INC
$69.01M$0.00-$50.47M-$49.76M-$1.72N/AN/AN/AN/A
ENHA
ENHANCED GROUP INC
$558.45M$17.70M-$86.83M-$87.13M-$3.15N/AN/AN/AN/A2026-11-12
EYPT
EYEPOINT INC
$331.92M$2.79M-$303.87M-$306.64M-$3.75-94.63%-41.05%N/AN/A2026-11-04
MIST
MILESTONE PHARMACEUTICALS INC
$114.04M$2.34M-$73.03M-$84.01M-$0.68N/A-31.02%N/AN/A2026-11-11
ADGM
ADAGIO MEDICAL HOLDINGS INC
$10.71M$0.00-$23.19M-$27.14M-$1.36-100.00%N/AN/AN/A2026-11-11
CLNN
CLENE INC
$55.89M$197.00k-$34.58M-$39.52M-$3.50-31.12%-18.29%N/AN/A2026-11-12
ALGS
ALIGOS THERAPEUTICS INC
$65.44M$31.52M-$72.59M-$75.96M-$7.40893.01%66.61%N/AN/A2026-11-05
CRBU
CARIBOU BIOSCIENCES INC
$139.37M$6.14M-$99.85M-$103.40M-$1.0849.70%3.20%N/AN/A2026-11-11
CABA
CABALETTA BIO INC
$432.34M$0.00-$159.94M-$181.32M-$1.52N/AN/AN/AN/A2026-11-09
NGEN
NERVGEN PHARMA CORP
$218.15M$0.00N/A-$44.48M-$0.55N/AN/AN/AN/A2026-11-12
LCTX
LINEAGE CELL THERAPEUTICS INC
$260.49M$13.08M-$36.80M-$32.26M-$0.1419.87%48.22%N/AN/A2026-11-05
MRLN
MERLIN INC
$197.08M$10.75M-$221.15M-$644.56M-$83.49122.18%N/AN/AN/A2026-11-12
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.